21 February 2024
Ludwig Oxford’s Yang Shi’s research team identifies KDM5C as a crucial sentinel for neurodevelopment.
6 February 2024
The Goding lab shows that Microphthalmia-associated Transcription Factor (MITF) plays a non-transcriptional role in shaping the DNA Damage Response programmes. MITF is phosphorylated on exposure to DNA damaging agents, and interacts with a DNA repair complex, increasing the level of genomic instability within cells which can have an impact on cancer initiation.
13 December 2023
Ludwig Oxford meets as a whole to share their science and creativity in talks, posters, writing and art competitions and more for the end of year retreat
30 November 2023
The Goding lab have worked in collaboration with Bill Pavan’s group of the National Human Genome Research Institute, at the National Institutes of Health (NIH), to uncover the transcriptomic profile of MC1R-inhibited melanocytes at single-cell resolution in Pigment Cell & Melanoma Research.
10 November 2023
Ludwig Oxford’s Olly Featherstone has been awarded an Early Career Excellent Teacher award by the Medical Sciences Division Teaching Excellence Awards.
Collaboration announced between Satisfai and University of Oxford to develop AI methods of evaluating Barrett's oesophagus
9 October 2023
An agreement between Satisfai Health Inc and the University of Oxford will forward the automated assessment of Barrett’s oesophagus, designed to determine patients with the highest risk of developing oesophageal cancer.
28 September 2023
Ludwig Oxford’s Colin Goding and his lab reveal an acetylation-mediated switch that suppresses differentiation and provides an explanation of why a human K206Q MITF mutation is associated with Waardenburg syndrome.
Ludwig Oxford’s Dr Mehdipour in one of three University of Oxford teams shortlisted for Cancer Grand Challenges funding
5 September 2023
Dr Parinaz Mehdipour is a member in one of the 12 teams shortlisted for funding from Cancer Grand Challenges, seeking to understand retrotransposable elements in cancer.
25 August 2023
Our new Leadership Fellow launches a research group in computational cancer genomics
Ludwig Oxford’s Richard White awarded for his Outstanding Research by the Society for Melanoma Research
18 August 2023
Richard White has been named for the 2023 Outstanding Research award by the Society for Melanoma Research
Comparative analysis of ADO and PHD enzymes allows researchers to better understand their co-evolution and integration into oxygen homeostasis mechanisms
17 August 2023
Ludwig Oxford’s Peter Ratcliffe and Tom Keeley have undertaken a comparative analysis of a number of enzymes involved in the adaption of cells to oxygen level changes.
11 July 2023
An analysis of samples obtained from a uniquely designed window-of-opportunity clinical trial (LUD2015-005) has shown that high tumour monocyte content (TMC) is an unexpected predictor of greater overall survival in inoperable oesophageal adenocarcinoma (OAC) patients.
15 June 2023
Laboratories at Ludwig Oxford have been awarded a Silver certificate for sustainability following the Laboratory Efficiency Assessment Framework (LEAF).
9 June 2023
Ludwig Oxford’s Xin Lu shows an unexpected suppression of KRAS and inflammation driven pancreatic cancer by the p53 suppressor iASPP.
8 June 2023
Team from the Van den Eynde group have discovered that some molecules previously used to treat hypertension might also help the immune system to better fight cancer cells
30 May 2023
1000 patients have been recruited for the Pearl study within the DeLIVER programme.